Business Summary
Adalvo Limited is a Malta-based global pharmaceutical company. The Company is a business to business (B2B) platform that offers the broad portfolio options for its partners as a single business unit. It offers generic small-molecule portfolio, which provides small-molecule portfolio with a focus in oncology; Value added (505b(2)) portfolio, offers Value added product portfolio with a focus on central nervous system (CNS); and peptide and biosimilar portfolio, offering peptide portfolio with a focus in rare diseases and diabetes, and biosimilar portfolio with a focus in immunology and oncology as well as ophthalmology.
Country of Incorporation
Malta
Incorporation Date
2018-08-17
Business Sector
Pharmaceuticals & Medical Research
Company Address
Malta Life Sciences Park, Building 1 Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate